Effect of rituximab on a salivary gland ultrasound score in primary Sjögren's syndrome: results of the TRACTISS randomised double-blind multicentre substudy.

Fisher, BA; Everett, CC; Rout, J; O'Dwyer, JL; Emery, P; Pitzalis, C; Ng, WF; Carr, A; Pease, CT; Price, EJ; +17 more... Sutcliffe, N; Makdissi, J; Tappuni, AR; Gendi, NST; Hall, FC; Ruddock, SP; Fernandez, C; Hulme, CT; Davies, KA; Edwards, CJ; Lanyon, PC; Moots, RJ; Roussou, E; Richards, A; Sharples, LD; Bombardieri, M; Bowman, SJ; (2017) Effect of rituximab on a salivary gland ultrasound score in primary Sjögren's syndrome: results of the TRACTISS randomised double-blind multicentre substudy. Annals of the rheumatic diseases. ISSN 0003-4967 DOI: https://doi.org/10.1136/annrheumdis-2017-212268

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1136/annrheumdis-2017-212268

Abstract

Share

Download

Filename: Effect of rituximab on a salivary_GOLD VoR.pdf

Licence: Creative Commons: Attribution 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar